BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8804738)

  • 1. The ups and downs of adenovirus vectors.
    Ginsberg HS
    Bull N Y Acad Med; 1996; 73(1):53-8. PubMed ID: 8804738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.
    Zhai Y; Yang JC; Kawakami Y; Spiess P; Wadsworth SC; Cardoza LM; Couture LA; Smith AE; Rosenberg SA
    J Immunol; 1996 Jan; 156(2):700-10. PubMed ID: 8543823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region.
    Ono HA; Le LP; Davydova JG; Gavrikova T; Yamamoto M
    Cancer Res; 2005 Nov; 65(22):10154-8. PubMed ID: 16287998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive expression of the adenovirus E3-14.7K protein does not prolong adenovirus vector DNA persistence but protects mice against lipopolysaccharide-induced acute hepatitis.
    Gantzer M; Spitz E; Accard N; Rooke R
    Hum Gene Ther; 2002 May; 13(8):921-33. PubMed ID: 12031125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.
    Benihoud K; Esselin S; Descamps D; Jullienne B; Salone B; Bobé P; Bonardelle D; Connault E; Opolon P; Saggio I; Perricaudet M
    Gene Ther; 2007 Mar; 14(6):533-44. PubMed ID: 17109009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel expression of mouse adenovirus type 1 early region 3 gp11K at late times after infection.
    Cauthen AN; Spindler KR
    Virology; 1999 Jun; 259(1):119-28. PubMed ID: 10364495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
    Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimpanzee-origin adenovirus vectors as vaccine carriers.
    Tatsis N; Tesema L; Robinson ER; Giles-Davis W; McCoy K; Gao GP; Wilson JM; Ertl HC
    Gene Ther; 2006 Mar; 13(5):421-9. PubMed ID: 16319951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The constitutive expression of the immunomodulatory gp19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector.
    Lee MG; Abina MA; Haddada H; Perricaudet M
    Gene Ther; 1995 Jun; 2(4):256-62. PubMed ID: 7552985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the E3 and L3 regions for arming oncolytic adenoviruses to achieve a high level of tumor-specific transgene expression.
    Robinson M; Ge Y; Ko D; Yendluri S; Laflamme G; Hawkins L; Jooss K
    Cancer Gene Ther; 2008 Jan; 15(1):9-17. PubMed ID: 17853920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats.
    Baxi MK; Deregt D; Robertson J; Babiuk LA; Schlapp T; Tikoo SK
    Virology; 2000 Dec; 278(1):234-43. PubMed ID: 11112498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor.
    Wold WS; Gooding LR
    Mol Biol Med; 1989 Oct; 6(5):433-52. PubMed ID: 2533958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted viruses.
    Berencsi K; Uri A; Valyi-Nagy T; Valyi-Nagy I; Meignier B; Peretz FV; Rando RF; Plotkin SA; Gönczöl E
    Lab Invest; 1994 Sep; 71(3):350-8. PubMed ID: 7933985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functions and mechanisms of action of the adenovirus E3 proteins.
    Lichtenstein DL; Toth K; Doronin K; Tollefson AE; Wold WS
    Int Rev Immunol; 2004; 23(1-2):75-111. PubMed ID: 14690856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion of the E3 region in an adenoviral vector decreases inflammation and neointima formation after arterial gene transfer.
    Wen S; Driscoll RM; Schneider DB; Dichek DA
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1777-82. PubMed ID: 11701465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor alpha stimulates expression of adenovirus early region 3 proteins: implications for viral persistence.
    Körner H; Fritzsche U; Burgert HG
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11857-61. PubMed ID: 1334549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenoviruses.
    Youil R; Toner TJ; Su Q; Casimiro D; Shiver JW; Chen L; Bett AJ; Rogers BM; Burden EC; Tang A; Chen M; Emini EA; Kaslow DC; Aunins JG; Altaras NE
    Hum Gene Ther; 2003 Jul; 14(10):1017-34. PubMed ID: 12869219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multigene expression from a replicating adenovirus using native viral promoters.
    Bauzon M; Castro D; Karr M; Hawkins LK; Hermiston TW
    Mol Ther; 2003 Apr; 7(4):526-34. PubMed ID: 12727116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus vectors deleted for genes essential for viral DNA replication.
    Schaack J
    Front Biosci; 2005 May; 10():1146-55. PubMed ID: 15769613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.